Ga onbeperkt met Magzter GOLD
Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts
Poging GOUD - Vrij
IVDs – The next big story after pharma
Bio Spectrum
|Decemeber 2019
The Indian In Vitro Diagnostics (IVDs) sector, included under the Make-in-India initiative of the Government of India, has huge market potential and is witnessing double-digit growth.
-
The IVDs market in India is estimated to be $1 billion currently and experiencing an annual growth of 15 per cent and has the potential to be a $1.8 billion industry by 2025 as per industry estimates. India is the fourth largest market for IVDs devices in Asia after China, Japan, and South Korea.
India being an emerging market is also evolving as a potential manufacturing hub for key global medical IVDs players and some IVDs companies such as Siemens, Arkray, Perkin Elmer, Sysmex Corporation, Randox and so on, have set up their manufacturing facilities in India.
India is till date dependent on imports for its IVDs needs with almost 80 per cent of IVDs being imported. The cost of manufacturing in the developed world is many times higher than the cost of manufacturing in India hence there has to be a strong push for MAKE IN INDIA IVDs’ to lower the healthcare costs in India.
Regulatory Landscape
Dit verhaal komt uit de Decemeber 2019-editie van Bio Spectrum.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Bio Spectrum
Bio Spectrum
Remidio unveils breakthrough in AI-enabled.retinal imaging for newborns
Bengaluru-based Remidio Innovative Solutions, a leader in artificial intelligence (AI)-powered ophthalmic devices, has announced the launch of Neubo 130, a next-generation ultra-widefield neonatal retinal imaging system designed to enhance precision diagnostics for neonatal retinal conditions like Retinopathy of Prematurity (ROP).
1 min
December 2025
Bio Spectrum
Biocon Biologics and Civica expand partnership to launch private-label insulin glargine in US
Bengaluru-based Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced expansion of its strategic collaboration with Civica, Inc. to include a new Insulin Glargine medicine that will benefit patients in the United States by increasing supply of high-quality affordable insulins.
1 min
December 2025
Bio Spectrum
C-CAMP signs MoU with NIMHANS to launch Centre for Bioentrepreneurship in Neurosciences and Mental Health
Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) and the National Institute of Mental Health and Neurosciences (NIMHANS), an institute of national importance, and the India’s largest public sector research organisation in mental health and neuroscience, have joined hands to set up a unique initiative – the Centre for Bioentrepreneurship in Neurosciences and Mental Health.
1 min
December 2025
Bio Spectrum
How India's Diabetes Crisis is Driving Med Devices Market
A growing diabetic population in India is a blessing for the care devices market. Both Indian and global diabetes care devices have taken this growing demand for various devices, kits as an opportunity to expand their market share. But the scope in rural areas seems a bit challenging for various companies due to less awareness about the disease, affordability etc. Let's look at this growing diabetes care devices market.
9 mins
December 2025
Bio Spectrum
Bharat Biotech launches Nucelion, CRDMO arm to focus on next-gen cell and gene therapy
Bharat Biotech International Ltd, announced the launch of Nucelion Therapeutics, a Contract Research Development and Manufacturing Organisation (CRDMO) focused on cell and gene therapies as its wholly owned subsidiary in Hyderabad.
1 min
December 2025
Bio Spectrum
Philips and Nicolab collaborate to advance stroke care in India
Dutch firm Philips is expanding its collaboration with Nicolab, The Netherlands-based company pioneering in artificial intelligence (AI)-powered stroke care, to advance stroke care in India.
1 min
December 2025
Bio Spectrum
Shilpa Medicare opens flow chemistry manufacturing centre in Bengaluru
Shilpa Medicare, a full-service contract development and manufacturing organisation (CDMO), has announced the launch of its new flow chemistry Centre of Excellence (CoE).
1 min
December 2025
Bio Spectrum
DPIIT signs MoU with Primus Partners to strengthen startup ecosystem
The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, Government of India, has signed a Memorandum of Understanding (MOU) with Primus Partners to enhance collaboration towards strengthening India's startup and innovation ecosystem.
1 min
December 2025
Bio Spectrum
Telangana targets Rs 1 lakh crore investments in Life Sciences by 2030
Telangana has set an ambitious target of attracting Rs 1 lakh crore in new investments in the Life Sciences sector by 2030, aiming to generate employment for five lakh people, as per Minister for IT and Industries Duddilla Sridhar Babu.
1 min
December 2025
Bio Spectrum
Siegwerk makes entry into pharma packaging segment in India with Rs 350 Cr investment
German firm Siegwerk has announced its strategic entry into the pharmaceutical packaging segment in India, reinforcing its commitment to consumer safety.
1 min
December 2025
Translate
Change font size